Osaka, Japan

Ryohei Eto

USPTO Granted Patents = 2 


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ryohei Eto: Innovator in Therapeutic Compounds

Introduction

Ryohei Eto is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds aimed at treating central nervous system diseases. With a total of two patents to his name, Eto's work is recognized for its potential therapeutic benefits.

Latest Patents

Eto's latest patents include a dihydrate of a benzothiophene compound or a salt thereof, along with a process for producing the same. The primary objective of this invention is to provide a compound that serves as a superior therapeutic agent for central nervous system diseases. Specifically, the invention details a dihydrate of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, along with the method for its production.

Career Highlights

Ryohei Eto is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic agents that can improve patient outcomes in the treatment of various diseases.

Collaborations

Eto collaborates with esteemed colleagues such as Hiroshi Yamashita and Tetsuya Sato, who share his commitment to advancing pharmaceutical research and development.

Conclusion

Ryohei Eto's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his dedication to improving therapeutic options for central nervous system diseases. His work at Otsuka Pharmaceutical Company, Limited, along with his collaborations, positions him as a key figure in the ongoing quest for effective medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…